medicine_0306 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Trevena partners with Imperial College London to assess TRV027

TRV027 will be assessed for its ability to modulate pathways involved in Covid-19 pathology. Credit: Jernej Furman.